 |
|
Dietary Phytoestrogens and Lung Cancer Risk
Matthew B. Schabath, PhD;
Ladia M. Hernandez, MS;
Xifeng Wu, MD, PhD;
Patricia C. Pillow, MS;
Margaret R. Spitz, MD, MPH
JAMA. 2005;294:1493-1504.
Context Despite lung-specific in vitro and in vivo studies that support a chemopreventive role for phytoestrogens, there has been little epidemiologic research focused on dietary intake of phytoestrogens and risk of lung cancer.
Objective To examine the relationship between dietary intake of phytoestrogens and risk of lung cancer.
Design, Setting, and Participants Ongoing US case-control study of 1674 patients with lung cancer (cases) and 1735 matched healthy controls. From July 1995 through October 2003, participants were personally interviewed with epidemiologic and food frequency questionnaires to collect demographic information and to quantify dietary intake of 12 individual phytoestrogens.
Main Outcome Measure Risk of lung cancer, estimated using unconditional multivariable logistic regression analyses stratified by sex and smoking status and adjusted for established and putative lung cancer risk factors.
Results Reductions in risk of lung cancer tended to increase with each increasing quartile of phytoestrogen intake. The highest quartiles of total phytosterols, isoflavones, lignans, and phytoestrogens were each associated with reductions in risk of lung cancer ranging from 21% for phytosterols (odds ratio [OR], 0.79; 95% confidence interval [CI], 0.64-0.97; P = .03 for trend) to 46% for total phytoestrogens from food sources only (OR, 0.54; 95% CI, 0.42-0.70; P<.001 for trend). Sex-specific effects were also apparent. For men, statistically significant trends for decreasing risk with increasing intake were noted for each phytoestrogen group, with protective effects for the highest quartile of intake ranging from 24% for phytosterols (OR, 0.76; 95% CI, 0.56-1.02; P = .04 for trend) to 44% for isoflavones (OR, 0.56; 95% CI, 0.41-0.76; P<.001 for trend), while in women, significant trends were only present for intake of total phytoestrogens from food sources only, with a 34% (OR, 0.66; 95% CI, 0.46-0.96; P = .01 for trend) protective effect for the highest quartile of intake. The apparent benefits of high phytoestrogen intake were evident in both never and current smokers but less apparent in former smokers. In women, statistically significant joint effects were evident between hormone therapy use and phytoestrogen intake. Specifically, high intake of the lignans enterolactone and enterodiol and use of hormone therapy were associated with a 50% (OR, 0.50; 95% CI, 0.31-0.68; P = .04 for interaction) reduction in risk of lung cancer.
Conclusions While there are limitations and concerns regarding case-control studies of diet and cancer, these data provide further support for the limited but growing epidemiologic evidence that phytoestrogens are associated with a decrease in risk of lung cancer. Confirmation of these findings is still required in large-scale, hypothesis-driven, prospective studies.
Author Affiliations: Department of Epidemiology, The University of Texas M. D. Anderson Cancer Center, Houston.
RELATED LETTERS
Phytoestrogens and Risk of Lung Cancer
, , , , , and
JAMA. ;295():755-755.
FULL TEXT
Phytoestrogens and Risk of Lung Cancer--Reply
and
JAMA. ;295():755-756.
FULL TEXT
RELATED ARTICLES
Effect of Smoking Reduction on Lung Cancer Risk
, , and
JAMA. ;294():1505-1510.
FULL TEXT
Reducing the Risk of Lung Cancer
and
JAMA. ;294():1550-1551.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Reduction of C-reactive protein with isoflavone supplement reverses endothelial dysfunction in patients with ischaemic stroke
Chan et al.
Eur Heart J 2008;29:2800-2807.
ABSTRACT
| FULL TEXT
Soy Phytochemicals Decrease Nonsmall Cell Lung Cancer Growth In Female Athymic Mice
Gallo et al.
J. Nutr. 2008;138:1360-1364.
ABSTRACT
| FULL TEXT
Dietary Boron and Hormone Replacement Therapy as Risk Factors for Lung Cancer in Women
Mahabir et al.
Am J Epidemiol 2008;167:1070-1080.
ABSTRACT
| FULL TEXT
Isoflavone intake in persons at high risk of cardiovascular events: implications for vascular endothelial function and the carotid atherosclerotic burden
Chan et al.
Am. J. Clin. Nutr. 2007;86:938-945.
ABSTRACT
| FULL TEXT
Inhaled Corticosteroids and Risk of Lung Cancer among Patients with Chronic Obstructive Pulmonary Disease
Parimon et al.
Am. J. Respir. Crit. Care Med. 2007;175:712-719.
ABSTRACT
| FULL TEXT
Lung cancer in never-smokers
Toh and Lim
J. Clin. Pathol. 2007;60:337-340.
FULL TEXT
Intakes of 4 dietary lignans and cause-specific and all-cause mortality in the Zutphen Elderly Study.
Milder et al.
Am. J. Clin. Nutr. 2006;84:400-405.
ABSTRACT
| FULL TEXT
Stage matters: choosing relevant model systems to address hypotheses in diet and cancer chemoprevention research
Fenton and Hord
Carcinogenesis 2006;27:893-902.
ABSTRACT
| FULL TEXT
Phytoestrogens and Risk of Lung Cancer
Hollman et al.
JAMA 2006;295:755-755.
FULL TEXT
Of Spices and Fruits and Wine
Van Way
JPEN J Parenter Enteral Nutr 2006;30:61-62.
FULL TEXT
Finally, Good News for Coffee Drinkers!
JWatch Women's Health 2005;2005:1-1.
FULL TEXT
What's new in the other general journals
Tonks
BMJ 2005;331:801-802.
FULL TEXT
Reducing the Risk of Lung Cancer
Dacey and Johnstone
JAMA 2005;294:1550-1551.
FULL TEXT
|
